N-linked oligosaccharides of cobra venom factor novel α(1-3)galactosylated LeX structures

D. Channe Gowda, John Glushka, Herman Van Halbeek, Rao N. Thotakura, Reinhard Bredehorst, Carl Wilhelm Vogel

    Research output: Contribution to journalArticlepeer-review

    24 Scopus citations

    Abstract

    Cobra venom factor (CVF), a nontoxic, complement-activating glycoprotein in cobra venom, is a functional analog of mammalian complement component C3b. The carbohydrate moiety of CVF consists exclusively of N-linked oligosaccharides with terminal α1-3-linked galactosyl residues, which are antigenic in human. CVF has potential for several medical applications, including targeted cell killing and complement depletion. Here, we report a detailed structural analysis of the oligosaccharides of CVF. The structures of the oligosaccharides were determined by lectin affinity chromatography, antibody affinity blotting, compositional and methylation analyses, and high-resolution 1H-NMR spectroscopy. Approximately 80% of the oligosaccharides are diantennary complex-type, Ο12% are tri- and tetra-antennary complex-type, and Ο8% are oligomannose type structures. The majority of the complex-type oligosaccharides terminate in Galα1-3Galβ1-4(Fucα1-3)GlcNAcβ1, a unique carbohydrate structural feature abundantly present in the glycoproteins of cobra venom.

    Original languageEnglish (US)
    Pages (from-to)195-208
    Number of pages14
    JournalGlycobiology
    Volume11
    Issue number3
    DOIs
    StatePublished - Mar 2001

    All Science Journal Classification (ASJC) codes

    • General Medicine

    Fingerprint

    Dive into the research topics of 'N-linked oligosaccharides of cobra venom factor novel α(1-3)galactosylated LeX structures'. Together they form a unique fingerprint.

    Cite this